Xanthoceras sorbifolia Bunge is a folk medicine in China. Recently, the triterpenoids in its husks have attracted more and more attention for potential prevention against Alzheimer's disease. However, current studies on its bioactive substances were still insufficient. To reveal more bioactive substances, an efficient and practical strategy based on high resolution mass spectra coupled with multiple data mining techniques was developed to characterize the barrigenol type triterpenoids in the husks and dosed rat plasma. A total of 50 barrigenol type triterpenoids were identified in the husks, and 6 of these were detected in the rat plasma, which were regarded as bioactive candidates. To find the real bioactive substances, the neuroprotective effect of the candidates was further tested by calculating the PC12 cell viability against amyloid-b-induced cytotoxicity. As a result, three out of the six candidates exhibited obvious neuroprotction against amyloid-b-induced cytotoxicity on PC12 cells, indicating their potential to be bioactive substances against Alzheimer's disease. This study will be a valuable reference of the bioactive substances in Xanthoceras sorbifolia Bunge husks against Alzheimer's disease and the provided strategy can also be applied to the exploration of the effective constituents in other medicines.
Introduction
Xanthoceras sorbifolia Bunge (X. sorbifolia), belonging to Sapindaceae, is a kind of indigenous shrub distributed around the north and northeast of China.
1,2 Its woods and fruit seeds were used as folk medicines for the treatment of rheumatism and pediatric nocturia. 3, 4 Recent study found that the husks with the advantages of abundant resource and low cost, were a promising medicinal resource. There were various chemical constituents in the husks, like triterpenoid saponins, coumarins, avonoids and sterols etc. [5] [6] [7] [8] Among them, barrigenol type triterpenoid saponins, rich in the husks, were its characteristic constituents and responsible for its multiple bioactivities, such as antitumor activity, anti-inammatory activity, and especially the potentiality against Alzheimer's disease (AD). [8] [9] [10] However, current studies on its bioactive substances against AD were insufficient. Most of them mainly focused on a monomer named xanthoceraside because it was rich in the husks and proved to exhibit excellent protection against amyloid-b (Ab)-induced cognitive disorder in rats. [11] [12] [13] [14] [15] [16] [17] [18] The neuroprotection of other saponins was rarely reported. For reasonable development and utilization of the husks, sufficient study on its bioactive substances against AD was very necessary. Nevertheless, intensive research on the neuroprotection of every saponin was time-consuming, labor-intensive and high-cost. According to Serum Pharmacochemistry of Traditional Chinese Medicines (SPT) theory, most bioactive constituents were rst absorbed into blood aer oral administration, and then exerted therapeutic effect aer metabolism and distribution. 19 Hence, components detected in the dosed plasma were more possible to exert efficacy in practice. Based on this principle, we tried to nd an efficient strategy to reveal the bioactive substances.
Thus, rstly, chemical proling of barrigenol type triterpenoids in the husks was carried out. However, as was widely believed, chemical proling of traditional chinese medicines (TCMs) was very time-consuming for its various components, complex matrices and unavailable analytical standards. Hence, an efficient and reliable analytical method seemed very important. Conventional techniques such as liquid chromatography and capillary electrophoresis in most cases could not satisfy the analysis of TCMs. In recent decades, high resolution mass spectrometry had gained popularity due to its accurate mass measurement, which simplied the process of identication and the analysis time was thus shortened. 20, 21 Therefore, in this study, an efficient and reliable ultra-high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-ight tandem mass spectrometry (UHPLC/ ESI-Q-TOF-MS/MS) method was established to screen and identify the effective components in X. sorbifolia husks. Thousands of high resolution MS and MS/MS data was obtained during chemical proling. To fast identify target ions from complex interference ions, a powerful data processing tool, PeakView 2.2 soware (Sciex, US), was applied to processing the original data automatically based on retention time, accurate mass molecular ion, isotopic pattern, and MS/MS library searching. In general, compounds in the same family were able to yield similar fragment ions or neutral loss molecules aer collision induced dissociation (CID). Thus, the modules of the product ion lter (PIF) and neutral loss lter (NLF) within the soware were applied to fast screen different kinds of barrigenol type triterpenoids by specifying the values of corresponding fragment ions or neutral loss molecules. 22 In this way, a large number of barrigenol type triterpenoid saponins in the husks were identied and a database with their detailed information was created. Then, the dosed rat plasma samples were detected using the same method, and barrigenol type triterpenoids absorbed into the blood were fast identied based on the database in vitro, which could be considered as the bioactive candidates. 19 Finally, the neuroprotective effect of the candidates was further tested by Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] induced cytotoxicity on PC12 cells to nd the real bioactive substances with the potentiality against AD.
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Up to now, there were few comprehensive studies on chemical proling of barrigenol type triterpenoids in X. sorbifolia husks. This work not only provided characteristic fragment pathways to fast screen different kinds of barrigenol type triterpenoids in the husks for the rst time, but also enriched its bioactive substances studies against AD. In addition, the provided strategy will be very useful for the exploration of effective substances in other medicines.
Experimental

Chemicals and materials
Chromatographic-grade methanol, acetonitrile and formic acid were supplied from Fisher Scientic (Fair Lawn, NJ, USA) and distilled water was purchased from Wahaha Co. Ltd (Hangzhou, China 
Preparation of X.sorbifolia husks extract
Dried powdered X. sorbifolia husks ($100 g) were extracted three times with 1000 ml of 70% ethanol under reux for 2 h. Aer ltering, the extraction was combined and concentrated under reduced pressure. The concentrate was redissolved with a concentration of 1 g crude drug per milliliter in water to obtain the solution and stored it at 4 C for animal oral administration.
One milliliter of intragastric administration (1 g ml À1 ) was diluted with 10 ml of water and passed through a 0.22 mm lter before UHPLC-MS analysis.
Animals experiment
Six healthy male Sprague-Dawley rats (220 AE 20 g) were provided by the Experimental Animal Center of Shenyang Pharmaceutical University and bred with free access to food and water in a stable-condition (22 AE 2 C temperature, 40-60% relative humidity) with a natural light-dark cycle for a week before the experiment to adapt the rats to the environment. Animal study was carried out following the Guideline of Animal Experimentation of Shenyang Pharmaceutical University, and the protocol was approved by the Animal Ethics Committee of the institution.
The rats were fasted 12 h with free access to water before oral administration of the husks extract at a dose of 10 g kg À1 . 1.0 ml of blood samples were collected from suborbital vein into heparinized tubes before and 2 h aer administration and immediately centrifuged at 1000 Â g for 10 min. The plasma samples were combined to make plasma pools, and then stored at À80 C until analysis.
Pre-processing of plasma samples
The frozen plasma samples were rst thawed to room temperature. An aliquot of 1 ml of pooling plasma samples was extracted with 3 ml of ethyl acetate and isopropanol (1 : 1, v/v). Then the mixture was vortex-mixed for 3 min and centrifuged at 10 000 Â g for 10 min. The supernatant was evaporated to dryness at 30 C under a stream of nitrogen, and then redissolved in 100 ml of methanol with vortex-mixing for 3 min. The supernatant was acquired aer centrifugation at 10 000 Â g for 5 min and 5 ml was injected into the UHPLC/ESI-Q-TOF-MS/MS system for further analysis.
Ab 25-35 preparation and cell culture
The core toxic peptide fragment derived from amyloid precursor protein, Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , 19 was dissolved in distilled water to obtain 1 mg ml À1 solution. Then the solution was incubated at 37 C for 7 days to induce the aggregation of Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , which exhibited strong neurotoxicity.
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The PC12 cells were routinely maintained in H-DMEM supplemented with 10% (v/v) heat-inactivated FBS, 100 IU ml À1 penicillin as well as 100 g ml À1 streptomycin at 37 C with 5% The TOF MS and CID MS/MS data was collected in both positive and negative electrospray ionization mode (ESI+/À) with dynamic background subtraction. The optimized operating parameters were listed as follows, source temperature, 550 C; ion spray voltage, 5500 V (ESI+)/À4500 V (ESIÀ); nebulizer gas, 50 psi; heater gas, 50 psi; curtain gas, 30 psi; declustering potential, 80 V (ESI+)/À80 V (ESIÀ); collision energy, 10 V (ESI+)/À10 V (ESIÀ). Information dependent acquisition were operated by a TOF-MS survey scan 100-1500 Da (100 ms) and up to 8 dependent TOF-MS/MS scans 50-1500 Da (100 ms) using collision energy of 60 V (ESI+)/À60 V (ESIÀ) with collision energy spread of AE 15 V. Mass tolerance was set as 50 mDa and continuous recalibration was executed every h injection using the calibrant delivery system. Operations and acquisition were all edited in the Analyst TF 1.6 soware panel (Sciex, USA).
3 Results and discussion
Chemical proling by UHPLC/ESI-Q-TOF-MS/MS
Barrigenol type triterpenoid saponins in X. sorbifolia husks were reported to exhibit multiple bioactivities, including alleviating cognitive decits, antitumor activities and anti-inammatory etc. 4, [10] [11] [12] [13] [14] [15] [16] [17] According to the presence of hydroxy at C-15 and/or C-16 and/or C-21 and/or C-22, they can be divided into three groups, known as barringtogenol C, R1-barrigenol and 16-deoxybarringtogenol C.
8 PIF and NLF in PeakView® 2.2 soware was chosen to fast screen compounds in different types by specifying the values of the corresponding fragment ions or neutral loss molecules. 26 The maximum tolerance of mass error was set as 5 ppm. Fragment ions in positive mode were selected to demonstrate the fragment pattern since higher sensitivity and more fragment ions were obtained. A total of 50 triterpenoid saponins were identied preliminarily and their structures were shown in Fig. 1 . Among them, 15 triterpenoids were unambiguously identied by comparing with the standards, other 25 triterpenoids were tentatively identied based on the reported information, and the rest 10 were rst identied in this study. Information of all the compounds was listed in Table S1 † and their XIC spectra were shown in Fig. S1(A and B) . † A total of twenty-one R1-barrigenol type triterpenoids were detected in husks extract with the same aglycone structure as shown in Fig. 1 . Sugar groups at C-3 as well as angeloyl groups at C-21 and/or C-22 were eliminated easily from the aglycone by CID. As a result, sugar moiety ions such as 493.11 (-GlcA + Gal + Ara) and 343.06 (-GlcA + Gal) were generated in the MS/MS spectra. To illustrate the possible fragmentation pathway in detail, one of the most abundant and widely reported saponins, xanthoceracide (compound 33), was selected as an instance. As shown in Fig. 2(A) indicating the composition of the sugar group at C-3. In the same way, other 14 R1-barrigenol type triterpenoids were identied preliminary, 26-30 among which, compounds 22, 34 and 39 were undoubted identied by comparing with the authentic standards. Then PIF and NLF modules were applied to explore unreported compounds. The product ion at m/z 493.11 was taken as an example to illustrate the detailed process. As Fig. S2(A and B) † showed, aer ltering process, interference peaks disappeared obviously and target peaks highlighted. Aer careful analysis, compounds 24 and 27 were picked out particularly since they were not searched in Chemspider online library or previous references. Their MS information indicated that they shared the same molecular formula with compound 31, whereas, their fragment pathways were different (Fig. S2(C and D) ). † In the MS/MS spectra of compounds 24 and 27, fragment ion at m/z 709.43 was observed, 116 Da more than m/z 593.38, suggesting the oxidation of one of the angeloyloxy groups. However, the accurate oxidized site was difficult to be conrmed only by the limited mass spectra information. The same strategy offered another four new ones (compounds 32, 37, 43 and 46) and their possible identities were listed in Table S1 . † For barringtogenol C type triterpenoids, functional groups were always substituted at C-21 (-Rha-Ang/-Rha-Ac) and/or C-16/22/28 (-Ac) of the aglycone, where the linkages could be broken easily by CID. 27 Its detailed fragment pathway was illustrated in Fig. 2(B) . Likewise, compounds 42, 45, 47 and 49 were also tentatively identied. 29, 30 Particularly, compounds 25 and 28 were highlighted aer PIF and NLF since they were not detected in Chemspider online library. A total of twenty 16-deoxybarringtogenol C type triterpenoids were identied in this study, which shared the same aglycone structure named 16-deoxybarringtogenol C (compound 36). Glycosyl groups consisted of glucose, rhamnose and/or angeloyl group were always substituted at C-3 and/or C-28. Thus, successive or simultaneous losses of sugar groups were observed in their MS/MS spectra. Take compound 10 as an instance (Fig. 2(C) MS spectrum, indicating the composition of sugar groups at C-3. Likewise, other nineteen 16-dexoybarringtogenol C type triterpenoids were tentatively identied, among which, compounds 6 and 7 were new.
In conclusion, a practical and reliable UHPLC-ESI-MS/MS method was rst established for chemical proling of barrigenol type triterpenoid saponins in X. sorbifolia husks extract, and a database with detailed information was shown in Table S1 , † which was very helpful for further exploration of bioactive substances.
3.2 Detection of barrigenol type triterpenoid saponins in rat plasma aer oral administration of X. sorbifolia husks TCMs usually exhibit advantages on the treatment of chronic and complicated disease for its characteristic of multicomponents, -targets and -pathways. However, it is too difficult to illustrate the molecular mechanism and effective substances thoroughly due to the diversity of its components.
Intensive study on the efficacy of every chemical component was time-consuming and unreasonable since TCMs exert therapeutic effects depended on the contribution of multiple constituents rather than individual ones. To solve the problem, SPT theory was proposed in early 1990s, 31 providing an efficient approach to discovery bioactive constituents which really worked in practice. It stated that most bioactive constituents in TCMs were rstly absorbed into blood aer oral administration, and then exerted therapeutic effects aer a series of complicated distribution and metabolism. Therefore, constituents in the dosed plasma are more possible to work in practice.
Current study on the bioactive substances of the husks against AD was insufficient. To discover the bioactive substances more efficiently, our attention was mainly focused on the constituents absorbed into blood. Their spectral information was collected by UHPLC/ESI-Q-TOF-MS/MS and analysed with PeakView® 2.2 soware at the same condition with Section 3.1. The compounds present in the dosed plasma and absent in the blank samples were selected. The prototype compounds could be fast identied by comparison with the information of database established in vitro. Eventually, only 6 prototype compounds, including four 16-deoxybarringtogenol C type triterpenoids, one barringtogenol C type triterpenoid and one R1-barrigenol type triterpenoid were identied in dosed plasma. XIC spectra of all the 6 compounds were shown in Fig. S1(C-F) . † Neither phase I nor phase II saponins metabolites were detected in the plasma samples aer oral administration of the husks, although a lot of attempts were tried in the preexperiments, including different pre-treatment methods (precipitation protein by methanol or acetonitrile, liquid-liquid extraction by ethyl acetate and isopropanol (1 : 1, v/v), and solid phase extraction by Waters Oasis) and detection of plasma samples at different time points (0.5 h, 1 h, 2 h, 4 h, 6 h, 8 h and 12 h). The results indicated that some of the barrigenol type triterpenoid saponins probably exerted efficacy as prototype components through absorbing into blood, while, others were probably to work in other ways, which needed further study. The speculation was consistent with the characteristics of TCMs, known as multi-components, targets and pathways.
Effect on Ab-induced PC12 cells damage
In the work, up to 50 barrigenol type triterpenoid saponins were tentatively identied, which could be divided into three types, known as R1-barrigenol type triterpenoid saponin, 16-deoxybarringtogenol C type triterpenoid saponin and barringtogenol C saponin. 8, 32 Among them, only one R1-barrigenol type triterpenoid saponin (compound 33), rich in the husks, had been reported as the effective substance against AD. [14] [15] [16] [17] [18] There are few reports on other saponins for the difficulty of their effective separation and complete identication. As shown in Fig. 1 , the structures of saponins in the same type were very similar, and their sugar chains usually contain 3 to 5 sugar residues, suggesting their high structural complexity, which resulted in the difficulty to obtain their standards. Fortunately, more than compound 33, some 16-deoxybarringtogenol C type triterpenoid saponins were also isolated and identied successfully in our previous study, 9 two of which (compound 10 and 17) were detected in the dosed rat plasma, implying their potentiality to work in practice according to SPT theory. Since little information was available on their neuroprotection, their neuroprotective effect was further tested by Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] induced cytotoxicity on PC12 cells. It was worth mentioning that compared to compound 33, the number and site of sugar groups and angeloyl groups on compound 10 and 17 were different. Therefore, we speculated the neuroprotection of compound 10 and 17 were probably different with the reported compound 33. To verify our speculation, the neuroprotective effect of compound 33 was also tested to compare to compound 10 and 17.
The test of Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] induced PC12 cells was widely applied to fast screen the compounds with potential neuroprotective effect.
14,23-25 Aer 24 h incubating with the 3 saponins (compounds 10, 17 and 33), the viability of PC12 cells was tested by MTT analysis. Fig. 3 demonstrated that the viability of the model groups, exposure to 20 mM Ab 25-35 for 24 h, signicantly degenerated compared with the control groups (p < 0.05), conrming the successful establishment of the model. As shown in Fig. 3, compound 33 (xanthoceracide) exhibited a signicant decrement on Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] induced PC12 cell death at a concentration of 0.01 mg ml À1 , whereas, it exhibited a strong cytotoxicity at a concentration of 0.1 mg ml À1 , which was consistent with previous research. 4, 14 As a kind of 16-deoxybarringtogenol C type triterpenoid saponin, compound 10 exhibited signicant neuroprotective effect at the concentration between 0.01 mg ml À1 and 0.1 mg ml À1 , and the best neuroprotective effect was shown at the concentration of 0.05 mg ml À1 . Similarly, the other 16-deoxybarringtogenol C type triterpenoid saponin, compound 17, also exhibited signicantly neuroprotection at the concentration of 0.01 mg ml À1 . At the higher concentration (0.1 mg ml À1 ), compounds 10 and 17 both exhibited much weaker cytotoxicity than compound 33. This phenomena could be explained by the presence of sugar groups at C-28 as well as the absence of angeloyl groups at C-21 and/or C-22. 4, 8, 32 The result suggested that the three compounds were all the bioactive substances of the husks against AD, but compound 10 and 17 belonging to 16-deoxybarringtogenol C type triterpenoid saponins showed weaker cytotoxicity than compound 33 at higher concentration. The neuroprotection of compound 10 and 17 was reported for the rst time, which will be an important reference for the further development of the husks.
Conclusions
In this study, a practical and efficient strategy was developed to reveal the bioactive substances of X. sorbifolia husks, systemically. A total of 50 barrigenol type triterpenoids were found in husks extract by an UHPLC-ESI-MS/MS method, 6 of which were detected in the dosed plasma as bioactive candidates based on the SPT theory. The neuroprotection of the candidates was further tested by Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] induced cytotoxicity on PC12 cells. As a result, three candidates, known as compounds 10, 17 and 33, exhibited signicant neuroprotection against Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] induced cytotoxicity on PC12 cells, indicating their potentiality against AD. The neuroprotection of compounds 10 and 17 was reported for the rst time. This work provided a signicant reference for the study of effective constituents in medicines.
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